Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.

ABSTRACT:

SUBMITTER: Morgan RD 

PROVIDER: S-EPMC7616995 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature